AstraZeneca effective against Brazil variant, reveals Oxford study

Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday (March 5).

Mar 05, 2021, 23:01 PM IST

Fake news alert: South Africa will not return 1 million AstraZeneca COVID-19 vaccines received from Serum Institute of India

South Africa had paused the rollout of AstraZeneca coronavirus vaccine doses this month after preliminary trial data showed they offered minimal protection against mild to moderate illness from the country's dominant COVID-19 variant. The country is now likely to administer Johnson & Johnson COVID-19 vaccines from Wednesday.

Feb 16, 2021, 19:55 PM IST

WHO gives AstraZeneca's COVID-19 vaccine emergency approval

The World Health Organization(WHO) has given emergency use approval to AstraZeneca's Covid-19 vaccine on Monday (February15) and allowed distribution to the world's poorest countries. WHO in its statement said that it had approved the usage of AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India vaccines.

Feb 15, 2021, 23:19 PM IST

WHO expert group recommends use of AstraZeneca vaccine for COVID-19

The advice is used by health care officials worldwide but doesn't amount to a WHO green light for the UN and its partners to ship the vaccine. That approval could come after separate WHO group meetings on Friday and Monday to assess whether an emergency-use listing for the AstraZeneca vaccine is warranted.

Feb 11, 2021, 01:08 AM IST

New advisory for COVID patients, WHO warns against high-dose anticoagulants

WHO spokeswoman Margaret Harris told a United Nations briefing in Geneva that the body suggests the use, of low-dose anticoagulants to prevent blood clots forming in blood vessels adding that higher doses may lead to other health complications. 

Jan 30, 2021, 09:02 AM IST

Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants

Pfizer Inc and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.

Jan 08, 2021, 17:34 PM IST

COVID-19 Vaccine dry run in Maharashtra's four districts

A dry run to assess the readiness of the mechanism laid out for the COVID-19 immunisation drive, which is expected to begin soon, was conducted on Saturday (January 2) in four districts of Maharashtra.

Jan 02, 2021, 15:34 PM IST

Reason behind dry run before corona vaccination

Know, why there is a need for the dry run campaign before Corona vaccination?

Jan 02, 2021, 13:20 PM IST

Corona vaccine's dry run in capital of every state

There is a dry run of the Corona vaccine today across the country, which will be in the capital of every state. This is a test to deliver the vaccine to tails of the states.

Jan 02, 2021, 10:44 AM IST

We will have an amazing New Year Today, After Vaccination approval?

The approval for a Covid vaccine can come soon, the country's drugs control authority has indicated.

Jan 01, 2021, 12:06 PM IST

DNA: Good and the bad news on coronavirus

Britain has approved the Corona vaccine of AstraZeneca. In this section of DNA, we will analyse the good and the bad news on the coronavirus.

Dec 30, 2020, 22:42 PM IST

Russia to test combination of COVID-19 shots with British AstraZeneca

Developers of the Russian coronavirus vaccine Sputnik V signed an agreement with British AstraZeneca.

Dec 22, 2020, 07:15 AM IST

India requires Rs 80,000 cr for vaccine distribution next year: SII

The Central government plans to vaccinate nearly 30 crore people in the first phase of the drive. It will be offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with comorbidities.

Dec 19, 2020, 13:24 PM IST

Corona Vaccine : Pfizer Seeks India Approval For Covid Vaccine

Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorization of its coronavirus vaccine.

Dec 06, 2020, 14:12 PM IST

Coronavirus Update : How will people get Corona Vaccine?

Experts believe that a COVID vaccine "will be ready in the next few weeks", Prime Minister Narendra Modi said. Watch the full Video.

Dec 05, 2020, 08:42 AM IST

Covishield is 'safe and immunogenic', has no side effects, asserts Serum Institute of India

The vaccine candidate, Covishield, is being developed by the UK's Oxford University and US pharma giant AstraZeneca. The SII is a manufacturing partner for the vaccine.

Dec 01, 2020, 13:44 PM IST

Know the status of 'Covaxin' vaccine for Coronavirus from Serum Institute, Pune

PM Narendra Modi is expected to visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and Oxford University for COVID-19 vaccine.

Nov 27, 2020, 20:48 PM IST

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Report

A new study would be run to evaluate a lower dosage that performed better than a full amount in AstraZeneca`s studies.

Nov 27, 2020, 02:16 AM IST

COVID-19: AstraZeneca admits manufacturing error in vaccine, results of trials affected

AstraZeneca and Oxford University on Wednesday admitted a manufacturing error while developing coronavirus COVID-19 vaccine.

Nov 26, 2020, 11:26 AM IST

After Pfizer and Moderna, Oxford-AstraZeneca COVID-19 vaccine can be 90% effective

Oxford-AstraZeneca, however, added that the efficacy of vaccine could be around 90 per cent under one dosing regimen.

Nov 23, 2020, 13:40 PM IST